Clinical parameters and HHV-6 active replication in relapsing-remitting multiple sclerosis patients

Area of Science:

• Neurovirology
• Immunology

Background:

• The exact cause of multiple sclerosis (MS) is unknown, but environmental factors are suspected.
• Investigating viral links like human herpesvirus-6 (HHV-6) is crucial for understanding MS etiology.

Purpose of the Study:

• To explore the potential association between human herpesvirus-6 (HHV-6) and relapsing-remitting multiple sclerosis (RRMS).
• To determine HHV-6 prevalence and viral load in RRMS patients compared to healthy controls.

Main Methods:

• A one-year follow-up study involving 63 RRMS patients and 63 healthy blood donors (HBD).
• Quantitative real-time PCR used to measure HHV-6 prevalence and viral load in serum samples.
• Collection of clinical data including age of onset and Expanded Disability Status Scale (EDSS) increase.

Main Results:

• HHV-6 was detected in 25.4% of RRMS patients over the follow-up year.
• Active HHV-6 infection was more prevalent during RRMS relapses (19.1%) than in remission (7.9%).
• HHV-6 variant A was the only type identified. Patients with active HHV-6 replication had an earlier disease onset (1.9 years sooner) and a greater EDSS increase.

Conclusions:

• A higher frequency of active HHV-6A infection appears associated with exacerbations in some RRMS patients.
• Further investigation is required to clarify the relationship between HHV-6A active infection and clinical outcomes in RRMS.